News

Oct 10, 2025 . 2 Min Read

FDA’s New ANDA Pilot: A Win for U.S. Manufacturing

FDA’s ANDA Prioritization Pilot: What It Means for U.S. Generics and CDMOs

Read More

Digital Confidence: Building Trust in Sterile Manufacturing

The sterile injectable space is evolving quickly, and capacity and compliance alone are no longer en...

Read More
1 Min. Read

Pharma Tariffs Push for U.S. Production

What the New Pharma Tariff Means for CDMOs and Sterile Injectables The U.S. just announced a propose...

Read More
1 Min. Read

American Injectables Announces Key Leadership Appointments to Drive Future Growth

American Injectables, a leading contract development and manufacturing organization (CDMO) specializ...

Read More
2 Min. Read

Special Considerations for Developing Parenteral Formulations

Compared to oral and transdermal medicine, parenteral formulations are potent and fast-acting. With ...

Read More
3 Min. Read

Strengthening the Pharmaceutical Supply Chain: It Starts With Formulation

The effects of supply chain issues are often most noticeable at the consumer level, manifesting as p...

Read More
3 Min. Read

Developing a Regulatory Strategy: Key Studies in the Formulation Stage

The FDA approval process is time-intensive and difficult for good reason. If you emerge on the other...

Read More
3 Min. Read

Formulation Development Process for Injectables: Your Steps to Success [Graphic]

Formulation development can take as long as three U.S. presidential terms. With that kind of time, i...

Read More
5 Min. Read

American Injectables Rolls Out Bold Rebrand

Brooksville, FL (July 11, 2024) — American Injectables, a pharmaceutical CDMO, recently debuted thei...

Read More
1 Min. Read

American Injectables Announces Validation of Its Tampa Operations

American Injectables is now well positioned to help fill the gap in US-based manufacturing of steril...

Read More
2 Min. Read